Sales & Marketing

On Monday, a handful of Big Pharma companies told Congress that they would put a six-month moratorium on drug ads for recently approved medication. Pfizer, Merck, Schering-Plough, and Johnson & Johnson also agreed to closely follow the American Medical Association's guidelines when using actors playing physicians in advertisements.

Do you really know who you are hiring? Agency Insider Mark Chataway spills the beans on why the pitch doesn't work, and what you need to do before signing on

At a time when current sales and marketing models are unsustainable, pharma is still slow to adopt online opportunities

When it comes to marketing, every syllable speaks volumes

Pharma is taking note of online video's power to affect B2B communications

American Red Cross scores a win against Johnson & Johnson in a legal battle over the use of one of the healthcare?s most recognizable symbols

FDA takes the opportunity to remind industry what reminder ads are, as promotional material for Shire's Fosrenol is deemed in violation of advertising rules

Marketers and sales reps feel the brunt of faltering Procrit sales as J&J consolidates its biologics divisions.

Consumer advertising might be taking a hit in the media and Congress, but pharma was all smiles at this year's PhAME Awards as the best DTC campaigns took the spotlight

Technology isn't the magic bullet, but it can help you hit your target

The tech-savvy creative team at Concentric Rx has its sales force mixing work and play

Thanks to Dr. Google and Nurse Yahoo, pharma consumers know better than ever how to get exactly what they want

Promotional spending is down as companies rationalize and optimize budgets. But in contrast to big changes on the sales side, marketers are still trying to make the old model work

As companies make headway with Web promotions, their marketers express concerns about how best to benchmark online efforts.

Blog entries about branded drugs-both positive and negative-are turning up in online keyword searches. Should pharma be worried?

GSK, Pfizer, and Merck have jumped on the cell-phone marketing bandwagon, but most of pharma is still tiptoeing around the technology. A new report details how pharma can get consumers to text for health info.

New study ranks the top RX product sites and looks at the consumers who view them

Talk to MDs in their language and build a better brand

What Big Pharma needs to learn-and value-about this rapidly growing US demographic

A new study looks at the movement of thought leaders and medical science liaisons from primarily marketing to other areas of the pharma company. Though the shift might be minor (7 percent since 2002), it might be a sign of things to come.

Now that Apple has opened its iPhone to third-party software developers, healthcare productivity programs are leading the charge. Here?s a preview of one of the frontrunners.

Pharma is still having a hard time earning the confidence of the key opinion elite, as only 56 percent claim they trust the industry.

A Kaiser Foundation study finds that although most Americans look favorably upon pharmaceuticals, they generally think drugs are too expensive and that most of the cost is blown on advertising.

Industry insiders explain how pharma companies are reorganizing their salesforces in the wake of industry-wide layoffs

New research points to the power of a highly educated sales force, supporting the case for a voluntary educational standard